The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Viral Vector Development Service Market Research Report 2024
Synopsis
The global Viral Vector Development Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Viral Vector Development Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Viral Vector Development Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Viral Vector Development Service in Pharmaceutical Manufacturers is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Viral Vector Development Service include UJIFILM Diosynth Biotechnologies, Sanofi, Spark Therapeutics, UniQure, MassBiologics, FinVector, Thermo Fisher Scientific (Brammer Bio), Cell and Gene Therapy Catapult and Cobra Biologics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Viral Vector Development Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Vector Development Service.
Report Scope
The Viral Vector Development Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Viral Vector Development Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Viral Vector Development Service companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
UJIFILM Diosynth Biotechnologies
Sanofi
Spark Therapeutics
UniQure
MassBiologics
FinVector
Thermo Fisher Scientific (Brammer Bio)
Cell and Gene Therapy Catapult
Cobra Biologics
Segment by Type
Retroviral Vectors
Lentiviral Vectors
Adenoviral Vectors
Adeno-associated Viral Vectors
Others Viral Vectors
Segment by Application
Pharmaceutical Manufacturers
Biotechnology Companies
Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Viral Vector Development Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Viral Vector Development Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Viral Vector Development Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Viral Vector Development Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Viral Vector Development Service in Pharmaceutical Manufacturers is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Viral Vector Development Service include UJIFILM Diosynth Biotechnologies, Sanofi, Spark Therapeutics, UniQure, MassBiologics, FinVector, Thermo Fisher Scientific (Brammer Bio), Cell and Gene Therapy Catapult and Cobra Biologics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Viral Vector Development Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Vector Development Service.
Report Scope
The Viral Vector Development Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Viral Vector Development Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Viral Vector Development Service companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
UJIFILM Diosynth Biotechnologies
Sanofi
Spark Therapeutics
UniQure
MassBiologics
FinVector
Thermo Fisher Scientific (Brammer Bio)
Cell and Gene Therapy Catapult
Cobra Biologics
Segment by Type
Retroviral Vectors
Lentiviral Vectors
Adenoviral Vectors
Adeno-associated Viral Vectors
Others Viral Vectors
Segment by Application
Pharmaceutical Manufacturers
Biotechnology Companies
Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Viral Vector Development Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Vector Development Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Retroviral Vectors
1.2.3 Lentiviral Vectors
1.2.4 Adenoviral Vectors
1.2.5 Adeno-associated Viral Vectors
1.2.6 Others Viral Vectors
1.3 Market by Application
1.3.1 Global Viral Vector Development Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Manufacturers
1.3.3 Biotechnology Companies
1.3.4 Research Institutes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral Vector Development Service Market Perspective (2019-2030)
2.2 Viral Vector Development Service Growth Trends by Region
2.2.1 Global Viral Vector Development Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Viral Vector Development Service Historic Market Size by Region (2019-2024)
2.2.3 Viral Vector Development Service Forecasted Market Size by Region (2025-2030)
2.3 Viral Vector Development Service Market Dynamics
2.3.1 Viral Vector Development Service Industry Trends
2.3.2 Viral Vector Development Service Market Drivers
2.3.3 Viral Vector Development Service Market Challenges
2.3.4 Viral Vector Development Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Vector Development Service Players by Revenue
3.1.1 Global Top Viral Vector Development Service Players by Revenue (2019-2024)
3.1.2 Global Viral Vector Development Service Revenue Market Share by Players (2019-2024)
3.2 Global Viral Vector Development Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Viral Vector Development Service Revenue
3.4 Global Viral Vector Development Service Market Concentration Ratio
3.4.1 Global Viral Vector Development Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Vector Development Service Revenue in 2023
3.5 Viral Vector Development Service Key Players Head office and Area Served
3.6 Key Players Viral Vector Development Service Product Solution and Service
3.7 Date of Enter into Viral Vector Development Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Vector Development Service Breakdown Data by Type
4.1 Global Viral Vector Development Service Historic Market Size by Type (2019-2024)
4.2 Global Viral Vector Development Service Forecasted Market Size by Type (2025-2030)
5 Viral Vector Development Service Breakdown Data by Application
5.1 Global Viral Vector Development Service Historic Market Size by Application (2019-2024)
5.2 Global Viral Vector Development Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Viral Vector Development Service Market Size (2019-2030)
6.2 North America Viral Vector Development Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Viral Vector Development Service Market Size by Country (2019-2024)
6.4 North America Viral Vector Development Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Viral Vector Development Service Market Size (2019-2030)
7.2 Europe Viral Vector Development Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Viral Vector Development Service Market Size by Country (2019-2024)
7.4 Europe Viral Vector Development Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Viral Vector Development Service Market Size (2019-2030)
8.2 Asia-Pacific Viral Vector Development Service Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Viral Vector Development Service Market Size by Region (2019-2024)
8.4 Asia-Pacific Viral Vector Development Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Viral Vector Development Service Market Size (2019-2030)
9.2 Latin America Viral Vector Development Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Viral Vector Development Service Market Size by Country (2019-2024)
9.4 Latin America Viral Vector Development Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Vector Development Service Market Size (2019-2030)
10.2 Middle East & Africa Viral Vector Development Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Viral Vector Development Service Market Size by Country (2019-2024)
10.4 Middle East & Africa Viral Vector Development Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 UJIFILM Diosynth Biotechnologies
11.1.1 UJIFILM Diosynth Biotechnologies Company Detail
11.1.2 UJIFILM Diosynth Biotechnologies Business Overview
11.1.3 UJIFILM Diosynth Biotechnologies Viral Vector Development Service Introduction
11.1.4 UJIFILM Diosynth Biotechnologies Revenue in Viral Vector Development Service Business (2019-2024)
11.1.5 UJIFILM Diosynth Biotechnologies Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Detail
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Viral Vector Development Service Introduction
11.2.4 Sanofi Revenue in Viral Vector Development Service Business (2019-2024)
11.2.5 Sanofi Recent Development
11.3 Spark Therapeutics
11.3.1 Spark Therapeutics Company Detail
11.3.2 Spark Therapeutics Business Overview
11.3.3 Spark Therapeutics Viral Vector Development Service Introduction
11.3.4 Spark Therapeutics Revenue in Viral Vector Development Service Business (2019-2024)
11.3.5 Spark Therapeutics Recent Development
11.4 UniQure
11.4.1 UniQure Company Detail
11.4.2 UniQure Business Overview
11.4.3 UniQure Viral Vector Development Service Introduction
11.4.4 UniQure Revenue in Viral Vector Development Service Business (2019-2024)
11.4.5 UniQure Recent Development
11.5 MassBiologics
11.5.1 MassBiologics Company Detail
11.5.2 MassBiologics Business Overview
11.5.3 MassBiologics Viral Vector Development Service Introduction
11.5.4 MassBiologics Revenue in Viral Vector Development Service Business (2019-2024)
11.5.5 MassBiologics Recent Development
11.6 FinVector
11.6.1 FinVector Company Detail
11.6.2 FinVector Business Overview
11.6.3 FinVector Viral Vector Development Service Introduction
11.6.4 FinVector Revenue in Viral Vector Development Service Business (2019-2024)
11.6.5 FinVector Recent Development
11.7 Thermo Fisher Scientific (Brammer Bio)
11.7.1 Thermo Fisher Scientific (Brammer Bio) Company Detail
11.7.2 Thermo Fisher Scientific (Brammer Bio) Business Overview
11.7.3 Thermo Fisher Scientific (Brammer Bio) Viral Vector Development Service Introduction
11.7.4 Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vector Development Service Business (2019-2024)
11.7.5 Thermo Fisher Scientific (Brammer Bio) Recent Development
11.8 Cell and Gene Therapy Catapult
11.8.1 Cell and Gene Therapy Catapult Company Detail
11.8.2 Cell and Gene Therapy Catapult Business Overview
11.8.3 Cell and Gene Therapy Catapult Viral Vector Development Service Introduction
11.8.4 Cell and Gene Therapy Catapult Revenue in Viral Vector Development Service Business (2019-2024)
11.8.5 Cell and Gene Therapy Catapult Recent Development
11.9 Cobra Biologics
11.9.1 Cobra Biologics Company Detail
11.9.2 Cobra Biologics Business Overview
11.9.3 Cobra Biologics Viral Vector Development Service Introduction
11.9.4 Cobra Biologics Revenue in Viral Vector Development Service Business (2019-2024)
11.9.5 Cobra Biologics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
